Breeding of new Artemisia annua variety "Kehao No.1" / 中国中药杂志

As a natural plant source of artemisinin,a first-line drug against malaria,Artemisia annua directly affects the extraction process of artemisinin and the source of artemisinin. At present,traditional breeding methods combined with tissue culture are often used to breed high-yield artemisinin-containing new varieties of A. annua. However,the breeding method has the disadvantages of low efficiency and continuous selection. In this study,heavy ion beam irradiation technology was used to observe the specific germplasm resources of A. annua,and the morphological characteristics,agronomic traits and artemisinin content were used as indicators to observe the selection materials and materials. The cultivated new varieties were compared with trials and regional trials. In addition,the new variety of A. annua was identified by SRAP molecular marker technology. The results showed that the new variety of A. annua, " Kehao No.1",had an average yield of 235. 0 kg of dry leaf per mu,which was more than 20% higher than that of the control. Especially,the average artemisinin content was 2. 0%,which was 45% higher than that of the control,and the " Kehao No.1" has high anti-white powder disease,high-yield and high-quality new varieties. Therefore,mutagenic breeding of heavy ion beam irradiation can significantly improve the yield and artemisinin content of the " Kehao No. 1" and it has a good promotion value.

Identification of neprilysin as a potential target of arteannuin using computational drug repositioning

ABSTRACT The discovery of arteannuin (qinghaosu) in the 20th Century was a major advance for medicine. Besides functioning as a malaria therapy, arteannuin is a pharmacological agent in a range of other diseases, but its mechanism of action remains obscure. In this study, the reverse docking server PharmMapper was used to identify potential targets of arteannuin. The results were checked using the chemical-protein interactome servers DRAR-CPI and DDI-CPI, and verified by AutoDock Vina. The results showed that neprilysin (also known as CD10), a common acute lymphoblastic leukaemia antigen, was the top disease-related target of arteannuin. The chemical-protein interactome and docking results agreed with those of PharmMapper, further implicating neprilysin as a potential target. Although experimental verification is required, this study provides guidance for future pharmacological investigations into novel clinical applications for arteannuin.

Dissimilaridade genética em variedades de Artemisia annua L. embasada em caracteres agronômicos, fisiológicos e fitoquímicos / Genetic dissimilarity in varieties of Artemisia annua L. based on agronomic, physiological and phytochemical characters

O presente estudo objetivou estimar a variabilidade genética existente entre caracteres agronômicos, fisiológicos e fitoquímicos em variedades de A. annua. O delineamento experimental foi inteiramente casualizado e os tratamentos foram as variedades Artemis, 2/39x5x3M, e 2/39x1V de A. annua, submetidas a avaliações agronômicas, fisiológicas e fitoquímicas. Para a realização das estimativas de distância genética foram geradas matrizes de dissimilaridade utilizando a distância Euclidiana e os métodos de agrupamento de Tocher e UPGMA. Além disso, avaliou-se a importância relativa dos caracteres para divergência genética pelo método de Singh. As análises foram realizadas pelo software Genes e os dendrogramas obtidos pelo NTSYS. A presença de variabilidade genética dentro das variedades permitiu a identificação de acessos dissimilares e com média elevada para as características estudadas. O número de ramificações, concentração intracelular de CO2, e o rendimento de óleo essencial foram os caracteres que mais contribuíram para a dissimilaridade genética de A. annua. Os acessos B24, C5 e C32 foram os mais promissores dentro das variedades e devem ser conservados para futuras hibridações, sendo que as hibridações mais promissoras na obtenção de populações segregantes desejadas são B24 x C5, B24 x C32 e C5 x C32.

This study aimed to estimate the genetic variability among agronomic, physiological, and phytochemical characters in varieties of A. annua. The experimental design was completely randomized and the treatments were the varieties Artemis, 2/39x5x3M and 2/39x1V of A. annua, subject to agronomic, physiological and phytochemical evaluations. To estimate the genetic distances, dissimilarity matrices were generated using the Euclidean distance and the Tocher and UPGMA grouping methods. Moreover, we evaluated the relative importance of the characters for genetic divergence through the method of Singh. The analyses were performed in the Genes software and the dendrograms were obtained from the NTSYS program. The presence of genetic variability within the varieties allowed the identification of dissimilar accessions with high average for all traits. The number of branches, intracellular concentration of CO2 and oil yield were the traits that contributed most to the genetic dissimilarity of A. annua. The accessions B24, C5 and C32 were the most promising within the populations and must be conserved for future crossings, and the most promising crosses to obtain the desired segregant populations were B24 x C5, B24 x C32 and C5 x C32.

Quantitation of artemether in pharmaceutical raw material and injections by high performance liquid chromatography / Quantificação de artemether a matéria-prima farmacêutica e injeções por cromatografia líquida de alto desempenho

The quantitation of artemether in both pharmaceutical raw material and injections was carried out by high performance liquid chromatography (HPLC) with ultraviolet detection. A Zorbax C18 column (150 x 4.6 mm; 5 μm), at 30 ºC, and a mobile phase composed of acetonitrile and water (70:30), at a flow rate of 1ml/min, were used. The detection wavelength was 216 nm and the injection volume was 20 μL. The method proved to be linear (r²=0.9999), precise (RSD < 20 percent for intra-day and inter-day precision), accurate and selective regarding possible impurities and excipients of the samples. The detection and quantitation limits were 8 μg/mL and 25 μg/mL, respectively. The artemether content obtained in the raw material analysis was 99.26 percent and in the injections, 102.08 percent. The optimized and validated method may be successfully employed to perform routine quality control analyses.

A quantificação de artemeter em matéria-prima farmacêutica e solução injetável foi realizada por cromatografia líquida de alta eficiência (CLAE) com detecção na região do ultravioleta. Empregou-se coluna Zorbax C18 (150 x 4.6 mm; 5 μm), mantida a 30 ºC, e fase móvel composta por acetonitrila e água (70:30), com fluxo de 1 ml/min. A detecção foi realizada a 216 nm, e o volume de injeção foi 20 μl. O método se mostrou linear (r²=0,9999), preciso (DPR < 2,0 por cento para precisão intra-dia e inter-dias) e seletivo em relação a possíveis impurezas e excipientes das amostras. Os limites de detecção e quantificação obtidos foram 8 μg/mL e 25 μg/mL, respectivamente. O teor médio de artemeter obtido na análise da matéria-prima farmacêutica foi 99,26 por cento e na solução injetável, 102,08 por cento. O método otimizado e validado pode ser utilizado com sucesso para análises rotineiras em controle de qualidade.

Evidence for the spectroscopic determination of artesunate in dosage form.

BACKGROUND & OBJECTIVES: Resistance to conventional antimalarials triggered off new policies to circumvent the devastating consequences of malaria especially in the trans-Saharan Africa. The use of artemisinin-based combinations as first line drug in treatment of uncomplicated malaria was then advocated and adopted by the World Health Organization (WHO). In Nigeria, this new policy has witnessed a surge in the number of circulating brands of such combinations. Unfortunately, at present, there are no "on-the-spot" cheap and reliable assay procedures for artesunate-based combinations. This is what the present research aims to achieve. METHODS: Ultraviolet absorption spectroscopy was used to establish the wavelength of maximum absorbance for pure powder of artesunate and then the Beer's plot generated. This was validated and used to assay nine brands (X1-X9) of artesunate in Nigerian drug market. RESULTS: Distinctive ultraviolet absorption at 287 nm of pure sample of Artesunate in simulated intestinal fluid (SIF) afforded a simple, precise and the most reliable method for the analysis of nine different brands of Artesunate marketed in Nigeria. SIF does not have any appreciable absorption in the ultraviolet region. This simple method yielded a Beer's plot for Artesunate with high correlation (R2) of 0.9972 +/- 0.00016 and was reproducible. The Beer's plot was obeyed in concentration range of 10-200 mg%. The limits of detection (sensitivity) and quantitation were found to be 0.471 mg/ml and 1.27 mg/ml respectively. The results showed that only four out of the nine brands assayed had deviations from label claims that were within acceptable limits. INTERPRETATION & CONCLUSION: Based on these convincing data, simple ultraviolet spectroscopy at 287 nm could be used to assay artesunate in formulations.